from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1429/-

LFCtreatmentdescriptionclass of inhibitor

-0.517

Amikacinug/mL Amikacintranslation

-0.300

Cap5-10ug/mL Capreomycintranslation

-0.539

Rox10-50 ug/mL Roxithromycintranslation

0.328

SM2-5 ug/mL Streptomycintranslation

-1.864

Tet5-10 ug/mL Tetracyclinetranslation

-1.457

Rif0.2-5ug/mL Rifampicintranscription

-0.704

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.030

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.437

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.148

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.758

Clofazimine10-13 ug/mL Clofaziminerespiration

0.281

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.360

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.054

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.272

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.317

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.492

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.156

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.244

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.794

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.277

KCN5-20 ug/mL Potassium cyaniderespiration

0.924

NaN30.2-2 mM Sodium aziderespiration

1.418

Nigericin50 uM Nigericinrespiration

-0.697

TRC10-150 ug/mL Triclosanrespiration

0.318

TRZ10-25 ug/mL Thioridazinerespiration

1.158

Valinomycin0.5-10 uM Valinomycinrespiration

1.286

ZnSO42 mM ZnSO4respiration

0.447

menadione6-10 ug/mL Menadionerespiration

0.080

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.101

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.443

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.649

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.720

NRP_1Non-replicating persistence stage 1dosRassociated

0.267

Amp0.2mg/mL AmpicillincellWall

0.096

Cephalexin20-100 ug/mL CephalexincellWall

0.649

Cerulenin0.32-5 ug/mL CerulenincellWall

0.563

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.130

EMB10-20 ug/mL EthambutolcellWall

0.434

Eta12-40 ug/mL EthionamidecellWall

0.817

INH0.2-0.4 ug/mL IsoniazidcellWall

0.063

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.025

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.242

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.745

BZA0.12 mg/mL BenzamidearomaticAmides

-0.824

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.379

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.081

H2O24 mM hydrogen peroxideDNAdamaging

0.204

Levo10 ug/mL LevofloxacinDNAdamaging

-0.367

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.893

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.889

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.316

UVUV-irradiationDNAdamaging

0.406

ARP41-4 ug/mL Antitubercular compound ARP4?

0.528

Antimycin12.5-50 ug/mL Antimycin A?

0.344

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.230

PA_110-50 ug/mL Antitubercular compound PA-1?

0.174

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.470

PA8240.2-2 ug/mL PA-824?

1.906

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.626

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.327

Verapamil50 uM Verapamil?

1.064

mercaptoethanol2 mM 2-Mercaptoethanol?

0.526

methoxatin10-20 ug/mL Methoxatin?